Summit Therapeutics Inc. Number of Reporting Units
Summit Therapeutics Inc. (SMMT) reported Number of Reporting Units of 1 reporting_unit for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2023-03-09
- Summit Therapeutics Inc. number of reporting units for fiscal 2022 was 1.00 reporting_unit, a 0.00% change from fiscal 2021.
- Summit Therapeutics Inc. number of reporting units for fiscal 2021 was 1.00 reporting_unit.
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2022-12-31 | 1.00 reporting_unit 10-K · filed 2023-03-09 |
| 2021-12-31 | 1.00 reporting_unit 10-K/A · filed 2022-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |